Approval · Notice of Compliance 22829 · 2019
IPG-DONEPEZIL: Notice of Compliance 22829
Issued October 28, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22829
- Date
- October 28, 2019
- Company
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Alternate api source. revisions to product monograph. updates to labelling
- Canadian reference product
- ARICEPT (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IPG-DONEPEZIL | Not yet assigned | — |
Medicinal ingredients
- DONEPEZIL HYDROCHLORIDE 5 MG per TAB
- DONEPEZIL HYDROCHLORIDE 10 MG per TAB